Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting

被引：0

作者：

Janapala, Rajesh Naidu ^{[1
]}

Patel, Jigar ^{[1
]}

Belfaqeeh, Omar ^{[1
]}

Pourmand, Ali ^{[1
]}

机构：

[1] George Washington Univ, Int Med Program, Sch Med & Hlth Sci, Washington, DC USA

来源：

INTERNATIONAL IMMUNOPHARMACOLOGY | 2021年 / 101卷

关键词：

Mild COVID-19; Hydroxychloroquine; HCQ; Hospitalization; Mortality;

D O I：

10.1016/j.intimp.2021.107878

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.

引用

页数：2

共 50 条

[21] The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study
Blair, Paul W.
Brown, Diane M.
Jang, Minyoung
Antar, Annukka A. R.
Keruly, Jeanne C.
Bachu, Vismaya S.
Townsend, Jennifer L.
Tornheim, Jeffrey A.
Keller, Sara C.
Sauer, Lauren
Thomas, David L.
Manabe, Yukari C.
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (02):
[22] Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19
Rosenberg, Eli S.
Holtgrave, David R.
Udo, Tomoko
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 38 - 39
[23] The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
Luis Ayerbe
Carlos Risco-Risco
Salma Ayis
Internal and Emergency Medicine, 2020, 15 : 1501 - 1506
[24] Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Arshad, Samia
Kilgore, Paul
Chaudhry, Zohra S.
Jacobsen, Gordon
Wang, Dee Dee
Huitsing, Kylie
Brar, Indira
Alangaden, George J.
Ramesh, Mayur S.
McKinnon, John E.
O'Neill, William
Zervos, Marcus
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 97 : 396 - 403
[25] No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"
Lebeaux, David
Revest, Matthieu
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 36
[26] Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine
Tejada Cifuentes, Francisco
Lloret Callejo, Angeles
Tirado Pelaez, Maria Jose
Rubio Pulido, Olga
Ruiz-Morote Aragon, Marta
Fernandez Urrusuno, Rocio
Munoz Carreras, Maria Isabel
Mendez Esteban, Maria Isabel
Maestre Sanchez, Victoria
Garcia Bonilla, Antonio
Paredero Dominguez, Jose Manuel
Arroyo Pineda, Virginia
Marco Tejon, Esther
Romero Candel, Gregorio
Fernandez Marchante, Ana Isabel
Marco del Rio, Jose
Ortiz Martin, Teresa
Lopez Sanchez, Piedad
MEDICINA CLINICA, 2021, 156 (04): : 166 - 171
[27] Is hydroxychloroquine beneficial for COVID-19 patients?
Xing Li
Ying Wang
Patrizia Agostinis
Arnold Rabson
Gerry Melino
Ernesto Carafoli
Yufang Shi
Erwei Sun
Cell Death & Disease, 11
[28] The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
Ayerbe, Luis
Risco-Risco, Carlos
Ayis, Salma
INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (08) : 1501 - 1506
[29] Efficacy of Hydroxychloroquine (HCQ) in treatment of COVID-19 infection in patients over 65 in Nursing Home setting
Goshtasbi, M.
Parulekar, M.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S100 - S100
[30] Is hydroxychloroquine beneficial for COVID-19 patients?
Li, Xing
Wang, Ying
Agostinis, Patrizia
Rabson, Arnold
Melino, Gerry
Carafoli, Ernesto
Shi, Yufang
Sun, Erwei
CELL DEATH & DISEASE, 2020, 11 (07)

← 1 2 3 4 5 →